MedTrace Logo

Calcium Dobesilate for Chronic Venous Wounds

NCT00979836 · Status: SUSPENDED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 230

Last updated 2011-02-17

No results posted yet for this study

Summary

The objective of the study is to assess the efficacy of calcium dobesilate for treating chronic venous wounds.

The hypothesis is that venous ulcers treated with standards measures (compressive measures) and calcium dobesilate will heal-up better than venous ulcers treated with standards measures (compressive measures) and placebo.

Conditions

  • Ulcer

Interventions

DRUG

Calcium Dobesilate

500 mg/ three times/day for 6 months (capsules)

Sponsors & Collaborators

  • Esteve Pharmaceuticals, S.A.

    collaborator INDUSTRY

  • Fundacion Iberoamericana Itaca

    lead OTHER

Principal Investigators

  • Moreno Carriles, Rosa Mª · Fundación de Investigación Biomédica - Hospital Universitario de La Princesa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2010-07-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00979836 on ClinicalTrials.gov